The postoperative platelet-to-lymphocyte ratio predicts the outcome of patients undergoing pancreaticoduodenectomy for pancreatic head cancer

Surg Today. 2024 Mar;54(3):247-257. doi: 10.1007/s00595-023-02727-4. Epub 2023 Jul 24.

Abstract

Purpose: The preoperative platelet-to-lymphocyte ratio (PLR) has been reported as an important prognostic index for pancreatic ductal adenocarcinoma (PDAC); however, the significance of the postoperative (post-op) PLR for this disease has not been elucidated.

Methods: We analyzed data on 118 patients who underwent pancreaticoduodenectomy for pancreatic head PDAC, collected from a prospectively maintained database. The post-op PLR was obtained by dividing the platelet count after surgery by the lymphocyte count on post-op day (POD) 14. The patients were divided into two groups according to a post-op PLR of < 310 or ≥ 310. Survival data were analyzed.

Results: A high post-op PLR was identified as a significant prognostic index on univariate analysis for disease-free survival (DFS) and overall survival (OS). The post-op PLR remained significant, along with tumor differentiation and adjuvant chemotherapy, on multivariate analysis for OS (hazard ratio = 2.077, 95% confidence interval: 1.220-3.537; p = 0.007). The post-op PLR was a significant independent prognostic index for poor DFS, along with tumor differentiation and lymphatic invasion, on multivariate analysis (hazard ratio = 1.678, 95% confidence interval: 1.056-2.667; p = 0.028).

Conclusions: The post-op PLR in patients with pancreatic head PDAC was an independent predictor of DFS and OS after elective resection.

Keywords: Adjuvant chemotherapy; Overall survival; Pancreatic ductal adenocarcinoma; Pancreaticoduodenectomy; Platelet-to-lymphocyte ratio.

MeSH terms

  • Blood Platelets
  • Carcinoma, Pancreatic Ductal* / surgery
  • Humans
  • Lymphocyte Count
  • Lymphocytes / pathology
  • Pancreatic Neoplasms* / pathology
  • Pancreaticoduodenectomy
  • Prognosis
  • Retrospective Studies